Key Takeaways
- bullet one
Fresenius Kabi has launched its denosumab biosimilars Bomyntra and Conexxence in Canada, joining an increasingly crowded market.
Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.